GoodRx Holdings, Inc. GDRX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $787.89M-1.2% | $796.85M+0.6% | $800.65M+1.3% | $799.87M+3.2% | $797.41M+4.4% | ||
| $64.39M+31.1% | $57.6M+19.5% | $52.33M+2.2% | $50.59M-13.1% | $49.11M-21.7% | ||
| $723.5M-3.3% | $739.26M-0.7% | $748.33M+1.2% | $749.28M+4.5% | $748.3M+6.7% | ||
| 91.8%-2.0pp | 92.8%-1.1pp | 93.5%-0.1pp | 93.7%+1.2pp | 93.8%+2.0pp | ||
| $120.06M-3.1% | $121.03M-2.2% | $123.83M-0.2% | $122.95M-7.9% | $123.87M-7.5% | ||
| $328.07M-9.3% | $331.56M-9.7% | $346.77M-5.5% | $353.11M-4.3% | $361.69M+2.5% | ||
| $111.15M+4.5% | $113.96M-3.3% | $113.57M-8.9% | $107.17M-20.2% | $106.38M-22.3% | ||
| $86.1M+15.6% | $85.22M+22.5% | $81.17M-13.7% | $77.27M-29.5% | $74.51M-31.4% | ||
| $709.77M-0.8% | $709.36M-2.4% | $717.66M-5.7% | $711.1M-11.6% | $715.57M-10.0% | ||
| $78.12M-4.6% | $87.49M+32.9% | $82.99M+182% | $88.78M+402% | $81.85M+365% | ||
| 9.9%-0.3pp | 11%+2.7pp | 10.4%+6.6pp | 11.1%+14.9pp | 10.3%+14.3pp | ||
| $41.73M-14.7% | $42.61M-19.5% | $43.56M-22.7% | $45.09M-23.3% | $48.92M-16.0% | ||
| $8.4M-57.3% | $10.93M-53.0% | $13.63M-49.8% | $16.12M-48.0% | $19.65M-39.5% | ||
| -$32.61M+4.1% | -$30.95M+10.0% | -$29.24M+13.9% | -$33.01M-10.3% | -$34.01M-21.7% | ||
| $45.51M-4.9% | $56.54M+79.7% | $53.75M+1,273% | $55.77M+194% | $47.84M+181% | ||
| $24.95M+28.7% | $26.1M+73.2% | $22M+112% | $21.17M+1,243% | $19.38M+136% | ||
| $20.56M-27.7% | $30.44M+85.7% | $31.75M+296% | $34.6M+159% | $28.45M+532% | ||
| 2.6%-1.0pp | 3.8%+1.8pp | 4%+6.0pp | 4.3%+11.9pp | 3.6%+4.4pp | ||
| $0.06-25.0% | $0.09+80.0% | $0.09+400% | $0.10+177% | $0.08+900% | ||
| $0.06-14.3% | $0.09+125% | $0.08+367% | $0.09+169% | $0.07+800% | ||
| 1.4B-9.2% | 1.4B-7.3% | 1.5B-6.2% | 1.5B-5.1% | 1.5B-5.1% | ||
| 1.4B-7.9% | 1.4B-6.1% | 1.5B-5.7% | 1.5B-5.6% | 1.5B-6.5% | ||
| $8.4M-57.3% | $10.93M-53.0% | $13.63M-49.8% | $16.12M-48.0% | $19.65M-39.5% | ||
| $787.89M-1.2% | $796.85M+0.6% | $800.65M+1.3% | $799.87M+3.2% | $797.41M+4.4% | ||
| $78.12M-4.6% | $87.49M+32.9% | $82.99M+182% | $88.78M+402% | $81.85M+365% | ||
| $164.22M+5.0% | $172.71M+27.6% | $164.16M+33.0% | $166.05M+107% | $156.35M+101% | ||
| $164.22M+5.0% | $172.71M+27.6% | $164.16M+33.0% | $166.05M+107% | $156.35M+101% | ||
| 20.8%+1.2pp | 21.7%+4.6pp | 20.5%+4.9pp | 20.8%+10.4pp | 19.6%+9.4pp | ||
| $78.12M-4.6% | $87.49M+32.9% | $82.99M+182% | $88.78M+402% | $81.85M+365% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is GoodRx Holdings, Inc.'s revenue?
- GoodRx Holdings, Inc. (GDRX) generated $787.9M in revenue over the trailing twelve months, down 1.2% year over year.
- Is GoodRx Holdings, Inc. profitable?
- GoodRx Holdings, Inc. reported $20.6M in net income over the trailing twelve months, a 2.6% net margin.
- What are GoodRx Holdings, Inc.'s profit margins?
- Gross margin is 91.8% and operating margin is 9.9%, with a 2.6% net margin.
- What is GoodRx Holdings, Inc.'s earnings per share?
- GoodRx Holdings, Inc.'s diluted EPS over the trailing twelve months is $0.06.
- Where does GoodRx Holdings, Inc.'s income statement data come from?
- Every line is extracted from GoodRx Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
